---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008145"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2025-05-27T23:59:59+00:00"
generated_at: "2026-05-20T10:13:40.082397+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Capricor stockholders approve 2025 Equity Incentive Plan (3.5M shares plus 5% annual increase)

## Summary
- Stockholders approved 2025 Equity Incentive Plan (3.5M shares reserved) with ~54% of votes cast in favor (9.7M FOR, 8.2M AGAINST).
- Plan includes annual evergreen increase of 5% of outstanding shares from 2026 through 2035.
- Rose, Snyder & Jacobs LLP ratified as independent auditor for FY2025.
- Say-on-pay advisory vote passed with ~92% in favor (16.4M FOR, 1.5M AGAINST).
- 30.55M shares present (66.9% of outstanding) at annual meeting on May 22, 2025.

## SEC filing metadata
- accession: 0001558370-25-008145
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2025-05-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837025008145/0001558370-25-008145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837025008145/capr-20250522x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008145
- JSON: https://secwatch.observer/filing/0001558370-25-008145.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008145.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.